Clinical Chemistry AACC Online Job Center
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Clinical Chemistry 34: 764-765, 1988;
This Article
Right arrow Full Text (PDF)
Right arrow Submit an electronic Letter to
the Editor about this paper
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Davenport, R. D.
Right arrow Articles by Keren, D. F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Davenport, R. D.
Right arrow Articles by Keren, D. F.

Clinical Chemistry, Vol 34, 764-765, Copyright © 1988 by American Association for Clinical Chemistry

Oligoclonal bands in cerebrospinal fluids: significance of corresponding bands in serum for diagnosis of multiple sclerosis

RD Davenport and DF Keren
Department of Pathology, University of Michigan Medical School, Ann Arbor 48109.

Controversy exists regarding the definition of oligoclonal bands in cerebrospinal fluid (CSF) and whether CSF bands with corresponding bands in the serum should be disregarded in the interpretation. Much of this controversy results from not distinguishing between the sensitivities of different techniques used for these studies. Because the combination isoelectric focusing/silver staining is more sensitive than agarose gel electrophoresis/Coomassie Blue staining for detecting weak bands, one would expect to find weak oligoclonal bands in the serum more frequently with the former technique than the latter. Yet, most clinical laboratories use agarose gel electrophoresis for this assay. To investigate the clinical relevance of CSF oligoclonal bands as compared with corresponding bands for serum by electrophoresis on agarose gel, we retrospectively reviewed paired CSF and serum electrophoretograms of 104 patients. We determined that the specificity of the oligoclonal-band test for diagnosis of multiple sclerosis was significantly enhanced by running paired CSF and serum specimens when CSF bands with corresponding serum bands were discounted.





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1988 by the American Association for Clinical Chemistry.